Oncological Diseases and Disorders: Clinical, Economic, and Humanistic Impacts

Recognizing that the value of pharmacists extends beyond clinical interventions to include cost-effective healthcare solutions and compassionate, patient-centered care, this new series of handbooks aims to fill this gap by showcasing the expanded roles and responsibilities of pharmacists. It will be first of its kind to provide comprehensive information about evidence-based pharmacist care, providing the latest research, guidelines, and up-to-date best practices.

This handbook series is unique in that each volume covers a specific topic, such as infectious diseases, gastrointestinal diseases, and cardiovascular diseases (to name just three areas) and will explore the impact of pharmacist care on patients in clinical settings, consider the economics and humanistic outcomes, as well as discuss the challenges and present helpful advice for implementing effective pharmacist care. The volumes will also delve into the implications, methods, and challenges of providing online and distance pharmacist care services for the specific diseases and conditions as well.

Volume 9: Oncological Diseases and Disorders a pivotal addition to Handbook of Evidence-Based Pharmacist Care series, focusing exclusively on the role of pharmacists in the field of oncology. This book comprehensively covers the pharmacist role in managing various cancer types, highlighting the clinical, economic, and humanistic impact of their care in oncology.

Oncology presents unique challenges due to the complexity of cancer treatments and the emotional and physical toll these diseases take on patients. Pharmacists play a crucial role in oncology care teams, contributing significantly to medication management, patient education, and supportive care. This book provides an in-depth exploration of these roles across different cancer types, emphasizing evidence-based practices and patient-centered care and including hormonal therapies, targeted therapies, chemotherapy, patient counseling, and supportive care, and management of side effects. Key topics covered in this book include breast cancer, colorectal cancer, lung cancer, prostate cancer, ovarian cancer, lymphomas, leukemias, liver cancer, stomach (gastric) cancer, skin cancer, and kidney (renal) cancer.

This book is an essential resource for pharmacists and healthcare professionals in the oncology field. Through evidence-based practices, case studies, and practical guidance, this provides pharmacists with information to enhance patient care in oncology, contributing to improved patient outcomes and healthcare efficiency.

Volumes in Handbook of Evidence-Based Pharmacist Care
Volume 1: Cardiovascular Diseases
Volume 2: Endocrine, Respiratory, and Renal Diseases and Disorders
Volume 3: Gastrointestinal Diseases and Disorders
Volume 4: Arthritis and Psychiatric Diseases and Disorders
Volume 5: System-Specific Infections
Volume 6: Widespread and Transmissible Infections
Volume 7: Skin Diseases and Conditions
Volume 8: Neurological, Hematological, and Urological Diseases and Disorders
Volume 9: Oncological Diseases and Disorders
Volume 10: Diseases and Disorders of Special Populations
Volume 11: Pharmacist Care in Special Services
Volume 12: Advanced Practices in Pharmacist Care
Volume 13: Pharmacist Skills and Competencies
Volume 14: Clinical Pharmacy, Advanced Pharmacist Practice, and Pharmacy Clinics: Case Studies from Around the World

Yaser Mohammed Al-Worafi, PhD, FRSPH (UK), is a Professor of Clinical Pharmacy at the College of Pharmacy, University of Science and Technology of Fujairah, United Arab Emirates. He has more than 20 years of experience in education, practice, research, and administration in Yemen, Saudi Arabia, United Arab Emirates, and Malaysia, having taught, prepared, designed, and written courses and programs for many universities on clinical pharmacy, pharmacy practice, social pharmacy, and patient care. He has authored over 100 peer-reviewed papers in international journals and book chapters and has edited more than 30 books. A fellow of the Royal Society of Public Health, UK, Prof. Yaser has been recognized globally for his contributions to pharmacy practice, education, and medication and patient safety and is listed as one of the Top 2% Scientists of the World by Stanford University. He is ranked among the best ten researchers globally in several key areas, highlighting his dedication and expertise in advancing medication safety and effectiveness.